DrGabrielFP Profile Banner
Gabriel Figueroa-Parra, MD, MSc Profile
Gabriel Figueroa-Parra, MD, MSc

@DrGabrielFP

Followers
627
Following
2K
Statuses
2K

Assistant Professor of Rheumatology @uanl | Former LUMEN Research Fellow @mayoclinic | Tweets are my own / ๐Ÿ˜โ˜•๐Ÿฉบ๐Ÿ“– / Left-handed.

25.68597,-100.346851
Joined June 2009
Don't wanna be here? Send us removal request.
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
3 years
Scientific Oath ๐Ÿ™‹๐Ÿปโ€โ™‚๏ธ I promise to work for a better world, where science and technology are used in socially responsible ways. I will not use my education for any purpose intended to harm human beings or the environment... 1/2
1
0
10
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
10 days
RT @JaimeFG_MD: ๐ŸšจNew Research Alert ๐Ÿšจ Excited to share our latest study in @TheLancetRheum We analyzed the accuracy, quality, and safetโ€ฆ
0
4
0
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
17 days
RT @jasonsknight: Antiphospholipid Antibodies Linked to Increased Risk for Diffuse Alveolar Hemorrhage in SLE
0
4
0
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
1 month
Happy to share our most recent review on glucocorticoids in patients with #lupus #nephritis! Thanks to @NDTsocial for publishing our work. @AliDuarteMD, Erika Navarro, Mario Bautista.
@hjanders_hans
Hans-Joachim Anders
2 months
Now online in @NDTsocial Optimal Glucocorticoid Therapy in Lupus Nephritis ๐ŸงThe review examines different dosing strategies, including IV pulse and oral regimens, and presents evidence of their efficacy and safety. โ–ถ๏ธ
Tweet media one
Tweet media two
1
2
11
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
3 months
RT @ACRheum: In a new summary of its 2024 Guideline for the Screening, Treatment, and Management of Lupus Nephritis, the ACR offers 41 recoโ€ฆ
0
18
0
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
3 months
RT @EBRheum: All-caps abstract text throw-down by Michelle Petri re:fractures in SLE ๐Ÿ˜† I keep saying this; our obsesssion with vitamin dโ€ฆ
0
7
0
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
3 months
RT @jasonsknight: Talked a little #antiphospholipid history ๐Ÿง before the forward-looking bits ๐Ÿ”ฎ #ACR24
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
20
0
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
3 months
RT @EBRheum: Happening now, new guidelines for mgmt. A few highlights: Recommend prompt GC therapy, pulse x1-3d followed by oral pred (<0โ€ฆ
0
22
0
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
3 months
1
0
1
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
3 months
RT @MithuRheum: ๐Ÿ†• #ACR24 | Updated Guidelines for Lupus Nephritis Treatment & Management ๐Ÿซ˜ Highlights ๐Ÿ”ถ โ€ข Critical role of renal biopsy โ€ขโ€ฆ
0
135
0
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
3 months
0
0
2
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
4 months
Felicidades Alรญ! Es un gran privilegio seguir aprendiendo de tan excepcionales personas. Que se arme la carnita asada!!!
@AliDuarteMD
Alรญ Duarte, MD
4 months
Iโ€™m incredibly honored to receive this award. Huge thanks to the @LupusOrg ! This is a shared achievement with my family, mentors, mentees, and patients. Excited to continue pushing lupus research forward!
1
0
4
@DrGabrielFP
Gabriel Figueroa-Parra, MD, MSc
4 months
Great work, congrats Mehmet @HocaogluMd!
@asawalha
Amr Sawalha, MD
4 months
Our rheumatology fellow @HocaogluMd first-author publication in A&R showing ANA production is primarily determined by non-genetic factors independent of lupus genetic risk @PittRheum @PittPediatrics @PittDeptofMed @UPMCPhysicianEd @ACR_Journals
1
0
2